A mortality risk score for septuagenarians undergoing orthotopic heart transplantation.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
03 2021
Historique:
revised: 30 11 2020
received: 30 09 2020
accepted: 07 12 2020
pubmed: 29 12 2020
medline: 2 7 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

With septuagenarians undergoing orthotopic heart transplantation (OHT) more frequently, we aimed to develop a risk score for 1-year mortality in this population. Septuagenarian OHT recipients were identified from the UNOS registry between 1987 and 2018. The primary outcome was 1-year post-OHT mortality. Patients were randomly divided into derivation and validation cohorts. Associated covariates were entered into a multivariable logistic regression model. A risk score was created using the magnitudes of the odds ratios from the derivation cohort, and its 1-year post-OHT mortality prediction capacity was tested in the validation cohort. A total of 1156 septuagenarians were included, and they were randomly divided into derivation (66.7%, n = 771) and validation (33.3%, n = 385) cohorts. An 11-point risk score incorporating 4 variables was created, which included mechanical ventilation, serum bilirubin, serum creatinine, and donor age. The predicted 1-year mortality ranged from 4.2% (0 points) to 48.1% (11-points) (p < .001). After cross-validation, the c-index was 0.67 with a Brier score of 0.10. Risk scores above 3 points portended a survival disadvantage at 1-year follow-up (p < .001). This 11-point risk score for septuagenarians is predictive of mortality within 1-year of OHT and has potential utilization in improving recipient evaluation and selection of elderly patients.

Sections du résumé

BACKGROUND
With septuagenarians undergoing orthotopic heart transplantation (OHT) more frequently, we aimed to develop a risk score for 1-year mortality in this population.
METHODS
Septuagenarian OHT recipients were identified from the UNOS registry between 1987 and 2018. The primary outcome was 1-year post-OHT mortality. Patients were randomly divided into derivation and validation cohorts. Associated covariates were entered into a multivariable logistic regression model. A risk score was created using the magnitudes of the odds ratios from the derivation cohort, and its 1-year post-OHT mortality prediction capacity was tested in the validation cohort.
RESULTS
A total of 1156 septuagenarians were included, and they were randomly divided into derivation (66.7%, n = 771) and validation (33.3%, n = 385) cohorts. An 11-point risk score incorporating 4 variables was created, which included mechanical ventilation, serum bilirubin, serum creatinine, and donor age. The predicted 1-year mortality ranged from 4.2% (0 points) to 48.1% (11-points) (p < .001). After cross-validation, the c-index was 0.67 with a Brier score of 0.10. Risk scores above 3 points portended a survival disadvantage at 1-year follow-up (p < .001).
CONCLUSIONS
This 11-point risk score for septuagenarians is predictive of mortality within 1-year of OHT and has potential utilization in improving recipient evaluation and selection of elderly patients.

Identifiants

pubmed: 33368696
doi: 10.1111/ctr.14202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14202

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Bleumink G, Knetsch A, Sturkenboom M, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J. 2004;25(18):1614-1619.
Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure. Circulation. 2002;106(24):3068-3072.
Adamson RM, Stahovich M, Chillcott S, et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device. J Am Coll Cardiol. 2011;57(25):2487-2495.
Kilic A, Weiss ES, Yuh DD, Shah AS, Conte JV. Factors associated with 5-year survival in older heart transplant recipients. J Thorac Cardiovasc Surg. 2012;143(2):468-474.
Demers P, Moffatt S, Oyer PE, Hunt SA, Reitz BA, Robbins RC. Long-term results of heart transplantation in patients older than 60 years. J Thoracic Cardiovasc Surg. 2003;126(1):224-231.
George TJ, Kilic A, Beaty CA, Conte JV, Mandal K, Shah AS. Septuagenarians bridged to heart transplantation with a ventricular assist device have outcomes similar to younger patients. Ann Thorac Surg. 2013;95(4):1251-1261.
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Hear Lung Transplant. 2016;35(1):1-23.
Cooper LB, Lu D, Mentz RJ, et al. Cardiac transplantation for older patients: characteristics and outcomes in the septuagenarian population. J Hear Lung Transplant. 2016;35(3):362-369.
Steyerberg EW, Harrell FE, Borsboom GJJ, Eijkemans MJ, Vergouwe Y, Habbema JDF. Internal validation of predictive models. J Clin Epidemiol. 2001;54(8):774-781.
Weiss ES, Allen JG, Kilic A, et al. Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. J Hear Lung Transplant. 2012;31(3):266-273.
Kilic A, Grimm JC, Shah AS, Conte JV, Whitman GJR, Sciortino CM. An easily calculable and highly predictive risk index for postoperative renal failure after heart transplantation. J Thorac Cardiovasc Surg. 2010;148(3):1099-1105.
Weiss ES, Allen JG, Arnaoutakis GJ, et al. Creation of a quantitative recipient risk Index for Mortality Prediction After Cardiac Transplantation (IMPACT). Ann Thorac Surg. 2011;92(3):914-922.
Joyce DL, Li Z, Edwards LB, Kobashigawa JA, Daly RC. Predicting 1-year cardiac transplantation survival using a donor-recipient risk-assessment tool. J Thorac Cardiovasc Surg. 2018;155(4):1580-1590.
Singh TP, Almond CS, Semigran MJ, Piercey G, Gauvreau K. Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Hear Fail. 2012;5(2):259-266.
Sorabella RA, Guglielmetti L, Kantor A, et al. Cardiac donor risk factors predictive of short-term heart transplant recipient mortality: an analysis of the United Network for organ sharing database. Transplant Proc. 2015;47(10):2944-2951.
Zuckermann A. Long-term survival (%3e10 years) of patients %3e60 years with induction therapy after cardiac transplantation. Eur J Cardio-Thoracic Surg. 2003;24(2):283-291.
Nagendran J, Wildhirt SM, Modry D, Mullen J, Koshal A, Wang SH. A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. J Card Surg. 2004;19(6):559-562.

Auteurs

Carlos E Diaz-Castrillon (CE)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Laura Seese (L)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Yeahwa Hong (Y)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Keith Dufendach (K)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Gavin Hickey (G)

Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Ibrahim Sultan (I)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Arman Kilic (A)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH